Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Dexcom
|
| gptkbp:acquisition |
gptkb:Type_Zero_Technologies
|
| gptkbp:analysis |
utilizes data analytics for product improvement
|
| gptkbp:approves |
FDA approved
|
| gptkbp:awards |
multiple industry awards
|
| gptkbp:ceo |
gptkb:2013
gptkb:Kevin_Sayer |
| gptkbp:clinical_trial |
conducts clinical trials for new products
|
| gptkbp:community |
active online user community
|
| gptkbp:community_engagement |
active in diabetes advocacy
|
| gptkbp:community_support |
supports diabetes education programs
|
| gptkbp:competitors |
gptkb:Roche
gptkb:Medtronic gptkb:Abbott |
| gptkbp:customer_base |
millions of users
|
| gptkbp:economic_impact |
expanding into new markets
|
| gptkbp:education |
provides educational resources for users
|
| gptkbp:employees |
over 1,000
|
| gptkbp:features |
user-friendly interfaces
|
| gptkbp:feedback |
focus on user experience
|
| gptkbp:financial_performance |
strong financial growth
|
| gptkbp:focus |
diabetes management
|
| gptkbp:founded |
gptkb:1999
|
| gptkbp:founder |
gptkb:Kevin_Sayer
|
| gptkbp:full_name |
gptkb:Dexcom,_Inc.
|
| gptkbp:global_presence |
available in multiple countries
|
| gptkbp:headquarters |
gptkb:San_Diego
gptkb:San_Diego,_California |
| gptkbp:healthcare |
integrates with healthcare systems
|
| https://www.w3.org/2000/01/rdf-schema#label |
DXCM
|
| gptkbp:industry |
gptkb:hospital
|
| gptkbp:innovation |
focus on innovative solutions for diabetes management
|
| gptkbp:invention |
numerous patents in glucose monitoring technology
|
| gptkbp:investment |
invests in technology innovation
highly regarded by investors |
| gptkbp:market |
regularly launches new products
|
| gptkbp:market_cap |
approximately $40 billion
|
| gptkbp:mission |
empower people with diabetes
|
| gptkbp:partnership |
gptkb:Abbott_Laboratories
|
| gptkbp:partnerships |
various healthcare organizations
collaborates with research institutions works with insurance companies for coverage |
| gptkbp:products |
continuous glucose monitoring systems
|
| gptkbp:provides_information_on |
follows clinical guidelines for diabetes care
|
| gptkbp:regulatory_compliance |
complies with healthcare regulations
|
| gptkbp:research_and_development |
significant investment
|
| gptkbp:revenue |
$1.5 billion (2022)
|
| gptkbp:scholarships |
offers patient support programs
|
| gptkbp:social_responsibility |
committed to corporate social responsibility
|
| gptkbp:sustainability_initiatives |
environmental responsibility programs
|
| gptkbp:symbol |
gptkb:DXCM
|
| gptkbp:technology |
real-time glucose monitoring
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:vision |
improve diabetes care
|
| gptkbp:website |
www.dexcom.com
|